Kosacz Barbara
Insider CIK 1763316 · ATHA Director · KRON COO & General Counsel · LWAC Director · PBAX Director · XOMA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 10,967 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 8,996 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 6,152 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 5,101 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 19,979 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 8,167 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 9,763 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | J Other | 2026-07-14 | 2026-07-14 | 6,269 | — | $0 | 0 | SEC↗ |
| LONA LeonaBio, Inc. | A Award deriv | 2026-06-23 | 2026-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| XOMA XOMA Royalty Corp | A Award | 2026-05-21 | 2026-05-26 | 3,586 | — | $0 | 9,557 | SEC↗ |
| LONA LeonaBio, Inc. | A Award deriv | 2026-04-09 | 2026-04-13 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-05-30 | 2025-06-03 | 20,900 | — | $0 | 20,900 | SEC↗ |
| XOMA XOMA Royalty Corp | A Award | 2025-05-21 | 2025-05-23 | 5,971 | — | $0 | 5,971 | SEC↗ |
| XOMA XOMA Royalty Corp | A Award | 2025-05-21 | 2025-05-23 | 5,971 | — | $0 | 5,971 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-05-24 | 2024-05-24 | 20,900 | — | $0 | 20,900 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2024-05-15 | 2024-05-17 | 9,763 | — | $0 | 9,763 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | J Other | 2024-02-14 | 2024-02-16 | 5,828 | — | $0 | 5,828 | SEC↗ |
| KRON Kronos Bio, Inc. | S Sale | 2024-01-04 | 2024-01-05 | 10,676 | $1.18 | $12.6K | 928,966 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2023-05-19 | 2023-05-22 | 20,900 | — | $0 | 20,900 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2023-05-17 | 2023-05-19 | 10,967 | — | $0 | 10,967 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2023-02-15 | 2023-02-17 | 208,367 | — | $0 | 208,367 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2023-02-15 | 2023-02-17 | 138,911 | — | $0 | 939,642 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2022-07-25 | 2022-07-27 | 53,600 | — | $0 | 791,624 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2022-05-20 | 2022-05-27 | 13,871 | — | $0 | 13,871 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2022-05-18 | 2022-05-20 | 8,996 | — | $0 | 8,996 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2022-02-15 | 2022-02-17 | 53,600 | — | $0 | 738,024 | SEC↗ |
| PBAX PHOENIX BIOTECH ACQUISITIO | J Other deriv | 2021-10-08 | 2021-10-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2021-05-19 | 2021-05-21 | 5,101 | — | $0 | 5,101 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2021-03-04 | 2021-03-08 | 27,742 | — | $0 | 27,742 | SEC↗ |
| LWAC Locust Walk Acquisition Co | J Other deriv | 2021-01-12 | 2021-01-14 | 17,500 | — | $0 | 17,500 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2020-12-09 | 2020-12-11 | 104,736 | — | $0 | 104,736 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2020-12-09 | 2020-12-11 | 69,824 | — | $0 | 684,424 | SEC↗ |
| KRON Kronos Bio, Inc. | P Buy | 2020-10-14 | 2020-10-16 | 5,250 | $19.00 | $99.8K | 614,600 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2020-05-20 | 2020-05-27 | 6,152 | — | $0 | 6,152 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2019-05-16 | 2019-05-20 | 8,167 | — | $0 | 8,167 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2019-01-01 | 2019-01-03 | 19,979 | — | $0 | 19,979 | SEC↗ |